Point-of-care and standard laboratory coagulation testing during cardiovascular surgery: Balancing reliability and timeliness

Journal of Clinical Monitoring and Computing

Volumn 15, Issue 3-4, 1999, Pages 197-204

  Fitch, Jane C K ^a,c   Mirto, Gayle P ^a   Geary, Kristin L B ^a   Byrne, Daniel W ^b   Hines, Roberta L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Byrne Research   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Coagulation testing; Laboratory turnaround times; Point of care testing

Indexed keywords

BIOMEDICAL EQUIPMENT; BLOOD; CLINICAL LABORATORIES; COAGULATION; EQUIPMENT TESTING; HEALTH CARE; RELIABILITY;

COAGULATION TESTING; LABORATORY TURNAROUND TIMES; POINT OF CARE TECHNOLOGY; STANDARD LABORATORY COAGULATION EQUIPMENT;

CARDIOVASCULAR SURGERY;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TEST; CARDIOVASCULAR SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL STANDARD UNIT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RELIABILITY; TIME; CARDIOPULMONARY BYPASS; CASE CONTROL STUDY; HEART DISEASE; HOSPITAL INFORMATION SYSTEM; INSTRUMENTATION; MIDDLE AGED; PERIPHERAL VASCULAR DISEASE; PROSPECTIVE STUDY;

AGED; BLOOD COAGULATION TESTS; CARDIOPULMONARY BYPASS; CASE-CONTROL STUDIES; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; POINT-OF-CARE SYSTEMS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0032780971     PISSN: 13871307     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009934804369     Document Type: Article

References (20)

1. Bick RL. Hemostatic defects associated with cardiac surgery, prosthetic devices, and other extracorporeal circuits. Semin Thromb Hemost 1985; 11: 249-280
2. Becker RC, Alpert JS. The impact of medical therapy on hemorrhagic complications following coronary artery bypass grafting. Arch Intern Med 1990; 150: 2016-2021
3. Hirsch J. Heparin. NEJM 1991; 324: 1565-1574
4. Nuttall GA, Oliver WC, Beynen FM et al. Intraoperative measurement of activated partial thromboplastin time and prothrombin time by a portable laser photometer in patients following cardiopulmonary bypass. J Cardiothor Vase Anesth 1993; 7: 402-409
5. Reich DL, Yanakakis MJ, Vela-Cantos FP et al. Comparison of bedside coagulation monitoring tests with standard laboratory tests in patients after cardiac surgery. Anesth Analg 1993; 77: 673-679
6. Despotis GJ, Santoro SA, Spitznagel E et al. On-site prothrombin time, activated partial thromboplastin time, and platelet count. Anesth 1994; 80: 338-351
7. Werner M, Gallagher JV, Ballo MS, Karcher DS. Effect of analytic uncertainty of conventional and point-of-care assays of activated partial thromboplastin time on clinical decisions in heparin therapy. AmJ Clin Pathol 1994; 102: 237-241
8. Bull, BS, Korpman RA, Huse WM, Briggs BD. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols. J Thorac Cardiovasc Surg 1975; 69: 674-684
9. Reinhardt AC, Tonneson AS, Bracey A et al. Minimum discard volume from arterial catheters to obtain coagulation studies free of heparin's effect. Heart Lung 1987; 16: 699-705
10. United States Department of Health and Human Services, Federal Register: U.S. Government Printing Office 1990; 55: 9495
11. van Rijn JLML, Schmidt NA, Rutten WPF. Correction of instrument and reagent based differences in determination of the international normalized ratio (INR) for monitoring anticoagulant therapy. Clin Chem 1989; 35: 840-843
12. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1307-1310
13. Carter AJ, Hicks K, Heidman AW, Resar JR, Laird JR, Coombs VJ, Blumenthal RS. Clinical evaluation of a microsample coagulation analyzer, and comparison with existing techniques. Cath Cardiovasc Diagnostic 1996; 39: 97-102
14. Naghibi F, Han Y, Dodds J, Lawrence CE. Effects of reagent and instrument on prothrombin times, activated partial thromboplastin times and patient/control ratios. Thromb Haemostasis 1988; 59: 455-463
15. Valenstein PN, and Emancipator K. Sensitivity, specificity, and reproducibility of four measures of laboratory turnaround time. AJCP 1989; 91: 452-457
16. Saxena S, Wong ET. Does the emergency department need a dedicated satellite laboratory? Continuous quality improvement as a management tool for the clinical laboratory. Clin Chem 1993; 100: 606-610
17. Hilborne LH, Oye RK, McArdle JE, Repinski JA, Rodgerson DO. Evaluation of stat and routine turn-around times as a component of laboratory quality. 1989; 91: 331-335
18. Despotis GJ, Santoro SA, Spitznagel E, Kater KM, Cox JL, Barnes P, Lappas DG. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 1994; 107: 271-279
19. Gilbert HC, Vender JS. The current status of point-of-care monitoring. Int Anesth Clin 1996; 34 (3): 243-261
20. Gaiser RR, Hayes T, Castro AD. Telephone reporting of blood analysis results into the operating room. Anesth Analg 1996; 82: 1284-1286